The prevalence of anti-K in Canadian prenatal patients

Transfusion

Volumn 55, Issue 6, 2015, Pages 1486-1491

  Goldman, Mindy ^a   Lane, Debra ^a   Webert, Kathryn ^a   Fallis, Robert ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ALLOANTIBODY; BACTERIAL ANTIGEN; K ANTIGENS; KEL PROTEIN, HUMAN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; METALLOPROTEINASE;

ADULT; ALGORITHM; ALLOIMMUNIZATION; ANTIBODY SCREENING; ARTICLE; AUTOMATION; BLOOD BANK; BLOOD DONOR; BLOOD GROUP KELL SYSTEM; CANADA; CANADIAN; COMPUTER PROGRAM; DATA BASE; ERYTHROCYTE; EUROPEAN; FEMALE; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREGNANCY; PRENATAL PERIOD; PRENATAL SCREENING; PREVALENCE; PROPHYLAXIS; TRANSFUSION; ADOLESCENT; BLOOD; BLOOD GROUP INCOMPATIBILITY; ERYTHROBLASTOSIS, FETAL; IMMUNOLOGY; MIDDLE AGED; NEWBORN; PRENATAL DIAGNOSIS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BLOOD GROUP INCOMPATIBILITY; CANADA; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; YOUNG ADULT;

EID: 84931574557     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13151     Document Type: Article

References (27)

1. Van der Schoot CE, Tax GH, Rijnders RJ, et al., Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003; 17: 31-44.
2. Eder AF,. Update on HDFN: new information on long-standing controversies. Immunohematology 2006; 22: 188-95.
3. Moise JK,. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008; 13: 207-14.
4. Moise JK,. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000; 92: 75-81.
5. Chandrasekar A, Morris KG, Tubman TR, et al., The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland. Ulster Med J 2001; 70: 89-94.
6. McKenna DS, Nagaraja HN, O'Shaughnessy R,. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999; 93: 667-73.
7. Dajak S, Čulic S, Stefanovic V, et al., Relationship between previous maternal transfusions and haemolytic disease of the foetus and newborn mediated by non-RhD antibodies. Blood Transfus 2013; 11: 528-32.
8. Koelewijn JM, Vrijkotte TG, de Haas M, et al., Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. BJOG 2009; 116: 655-664.
9. Kamphuis MM, Lindenburg I, van Kamp IL, et al., Implementation of routine screening of Kell antibodies: does it improve perinatal survival? Transfusion 2008; 48: 953-7.
10. Rath ME, Smits-Wintjens VE, Lindenburg IT, et al., Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease. Vox Sang 2011; 100: 312-6.
11. Babinszki A, Lapinski RH, Berkowitz RL,. Prognostic factors and management in pregnancies complicated with severe Kell alloimmunization: experiences of the last 13 years. Am J Perinat 1998; 15: 695-701.
12. Vaughan JI, Manning M, Warwick RM, et al., Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798-803.
13. Kraegel J,. CSA (Canadian Standards Association) Z902-10 blood and blood components. Mississauga: Canadian Standards Association; 2010.
14. American Association of Blood Banks. Standards for blood banks and transfusion services. 29th ed. Bethesda (MD): AABB Press; 2014.
15. Haematology guidelines [Internet]. London: British Committee for Standards in Haematology; 2012 [cited 2014 Jul 23]. Available from: http://www.bcshguidelines.com/4-HAEMATOLOGY-GUIDELINES.html.
16. Transfusion de globules rouges homologues: produits, indications, alternatives [Internet]. Saint-Denis: French Agency for the Safety of Health Products; 2002 [cited 2014 Jul 23]. Available from: http://www.srlf.org/rc/org/srlf/htm/Article/2011/20110907-224516-271/src/htm-fullText/fr/2002-08-AFSSAPS-recommandations-pratiques-cliniques-transfusion-de-globules-rouges-homologues.pdf
17. National Users' Board, Sanquin Blood Supply. Blood transfusion guideline [Internet]. Amsterdam: Sanquin Blood Supply; 2011 [cited 2014 July 23]. Available from: http://www.sanquin.nl/repository/documenten/en/prod-en-dienst/287294/blood-transfusion-guideline.pdf
18. Bonnes pratiques de transfusion à l'usage des hôpitaux [Internet]. Brussels: Superior Health Council; 2010 [cited 2014 July 23]. Available from: http://www.health.belgium.be/internet2Prd/groups/public/@public/@shc/documents/ie2divers/10666440-fr.pdf
19. Bundesärztekammer, Paul-Ehrlich-Institut Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie)-Gesamtnovelle 2005. Bundesanzeiger 2005; 57: 4-35.
20. Pahuja S, Gupta SK, Pujani M, et al., The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus 2011; 9: 388-93.
21. Lee CK, Ma ES, Tang M, et al., Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy-a review of cases from 1997 to 2001. Transfus Med 2003; 13: 227-231.
22. Summary tables [Internet]. Ottawa: Statistics Canada; 2012 [cited 2014 July 23]. Available from: http://statcan.gc.ca/tables-tableaux/sum-som/index-eng.htm
23. Preventing HDFN with transfusion matching of females of childbearing potential-AMIGO [Internet]. Lebanon (NH): BEST Collaborative; 2012 [cited 2014 July 23]. Available from: http://bestcollaborative.org/index.php/mission-menu/studieslist/details/1/225/best-studies-68.html
24. O'Brien KL, Kim YA, Haspel RL, et al., Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review. Transfusion 2014; 55: 599-604.
25. Flegel WA, von Zabern I, Wagner FF,. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009; 49: 465-71.
26. Hogervorst E, Middelburg R, Brand A, et al., Anti-K formation is not associated with the storage time of transfused red blood cells. Transfusion 2015 DOI: 10.1111/trf.12974.
27. Westhoff CM,. Molecular genotyping for RHD: what (not) to do? Transfusion 2007; 47: 1337-9.